Christoph Fueweger

Papers

1

Total Citations

9

H-Index

1

About

Christoph Fueweger is a leading figure in the field of stereotactic body radiotherapy (SBRT), with a particular focus on the treatment of liver metastases using robotic radiosurgical devices. His major contribution lies in demonstrating the long-term efficacy of non-invasive, high-precision radiation for patients with oligometastatic liver disease—a rapidly evolving alternative to surgical resection. In his most-cited work, "Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver Metastases," Fueweger provides critical survival data that helps bridge the gap between radiotherapy and surgical outcomes, offering clinicians evidence for curative-intent, non-surgical options. With 9 citations, this study has become a reference point for researchers exploring the CyberKnife system’s role in liver-directed therapy. Beyond this, Fueweger’s research continues to shape protocols for motion management and dose escalation in abdominal radiosurgery. His work is especially valuable for students and clinicians seeking to understand how technological advances in robotic radiosurgery are redefining the boundaries of local tumor control.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver Metastases
9 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 5

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago